THC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis

Rehabilitation in practice: Spasticity management

(2010) VL Stevenson   CLINICAL REHABILITATION

P.6.c.010 Abuse potential of nabiximols oromucosal spray compared with dronabinol and placebo in recreational marijuana users

(2010) K.A. Schoedel et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis

(2010) Derick T Wade et al.   Multiple Sclerosis Journal

Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis

(2010) RBC Kavia et al.   Multiple Sclerosis Journal

A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis

(2010) C. Collin et al.   NEUROLOGICAL RESEARCH

Stop using the Ashworth Scale for the assessment of spasticity

(2009) J F M Fleuren et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Cannabis use and risk of lung cancer: a case-control study

(2008) S. Aldington et al.   EUROPEAN RESPIRATORY JOURNAL

Cannabis use in Spanish patients with multiple sclerosis: Fulfilment of patients' expectations?

(2008) Jose E. Martínez-Rodríguez et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Cannabinoid pharmacology: the first 66 years

(2006) Roger G Pertwee   BRITISH JOURNAL OF PHARMACOLOGY